Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ:LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease test kits, announced that its LUCIRA™ CHECK IT COVID-19 Test Kit, a self-administered PCR quality, single-use, at home molecular diagnostic test for COVID-19, is available for purchase by Amazon U.S.-customers.
“We are delighted that our LUCIRA™ CHECK IT COVID-19 test kit is once again available to Amazon U.S.-customers,” said Erik Engelson, Chief Executive Officer. “Access to a COVID-19 test with the PCR-level accuracy and early detectability that you get from a lab test combined with the speed and simplicity of our test kit can help Americans confidently return to work or school and to get back to gathering live with family and friends this upcoming holiday season. Amazon’s reach enables more people in the United States access to this innovative and unique testing solution.
The test kit, authorized for emergency use by FDA under EUA, is available over the counter (“OTC”), and can produce a positive result in as little as 11 minutes, or a negative result within 30 minutes. Immediately after testing, users can access a free, text based digital LUCI PASS™ verified test result on their phone for work, travel, and leisure.
